{"id":"W4416086893","doi":"10.1182/bloodadvances.2025016845","title":"A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Ipsen; Mallinckrodt Pharmaceuticals; Seagen; National Institutes of Health; Incyte; BeiGene; Genentech; AstraZeneca","keywords":"Lenalidomide; Blinatumomab; Concomitant; Adverse effect; Phases of clinical research; Toxicity; Lymphoma; Neurotoxicity","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003097143,0.0007773245,0.001109984,0.0004811326,0.0003192301,0.0007986968,0.0007614521,0.0007508852,0.001617731],"category_scores_gemma":[0.001015836,0.0004318488,0.0007983167,0.0004904788,0.0006184386,0.0004002641,0.0002370706,0.001847473,0.0003391441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008467202,"about_ca_system_score_gemma":0.0013292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00068104,"about_ca_topic_score_gemma":0.001485092,"domain_scores_codex":[0.9992855,0.0004249983,0.00003964978,0.00009055202,0.0001018524,0.00005747307],"domain_scores_gemma":[0.9990941,0.0001897394,0.0002487702,0.00009700076,0.00009016891,0.0002801993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4688989,0.09955745,0.05481338,0.001476104,0.003102195,0.001224067,0.0004639191,0.005247677,0.2243632,0.0004286717,0.00386672,0.1365579],"study_design_scores_gemma":[0.2647393,0.6238484,0.06703521,0.00009142209,0.001736028,0.001713537,0.000129575,0.004034244,0.03073361,0.0003217695,0.005558805,0.0000580697],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950505,0.00223752,0.0003927076,0.0001271221,0.00002553595,0.001001742,0.0005795255,0.00004005075,0.000545401],"genre_scores_gemma":[0.9935962,0.001112175,0.001620075,0.0003614007,0.00007532311,0.0007167225,0.001690925,0.00001777523,0.0008093528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003097143,"threshold_uncertainty_score":0.01637948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619469634600543,"score_gpt":0.3483985157154631,"score_spread":0.3322038193694576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}